3 Things DCAT 2026 Made Clear About Pharma Right Now
At SCx CMC Solutions, we attend events like DCAT for a simple reason: if you want to understand where the pharmaceutical industry is actually headed, you have to pay attention […]
FDA IND CMC Requirements for Biologics: A 2025 Sponsor’s Checklist
The path from a promising biologic drug product to an approved medicine begins long before Phase I Clinical Trials. For drug sponsors, one of the most critical early steps is […]
From API to Clinic: Structuring Your Development Roadmap
The journey from creating an active pharmaceutical ingredient (API) to administering the first human dose is one of the most resource-intensive and strategically critical phases in drug development. While science […]
Why Pharmaceutical Development Services Matter Early in CMC
In the critical and very competitive world of pharmaceutical product development, timing is extremely important. Regulatory deadlines, investor expectations, and market competition create intense pressure on the pharmaceutical sponsors to […]